PATENT CLAIM ANALYSIS

Application Number: 15977512
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["546", "152000"]

Abstract:
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, W 1 , W 2 , W 3 , and R 1 -R 8  are described herein.

Claim (Index 63):
A pharmaceutical composition comprising (S)-4-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-2-methoxybenzonitrile, or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 155.0
- Percentile: 93.0
- Lexical Diversity: 1.2619
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14858174', '15964812', '15568051', '14858170', '14858167']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7984171363029183
- 35 USC 102 Novelty (BERT): 0.5307754146949902
- Combined Prediction Score: 0.7716529641421256
- Mean Citation Score: 351.024596
- Max Citation Score: 371.9124
- Similarity Product: 318.00315360674864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test